The newly emergent Middle East respiratory syndrome coronavirus (MERS-CoV) can cause severe pulmonary disease in humans 1, 2 , representing the second example of a highly pathogenic coronavirus, the first being SARS-CoV 3 . CD26 (also known as dipeptidyl peptidase 4, DPP4) was recently identified as the cellular receptor for MERSCoV 4 . The engagement of the MERS-CoV spike protein with CD26 mediates viral attachment to host cells and virus-cell fusion, thereby initiating infection. Here we delineate the molecular basis of this specific interaction by presenting the first crystal structures of both the free receptor binding domain (RBD) of the MERS-CoV spike protein and its complex with CD26. Furthermore, binding between the RBD and CD26 is measured using real-time surface plasmon resonance with a dissociation constant of 16.7 nM. The viral RBD is composed of a core subdomain homologous to that of the SARSCoV spike protein, and a unique strand-dominated external receptor binding motif that recognizes blades IV and V of the CD26 b-propeller. The atomic details at the interface between the two binding entities reveal a surprising protein-protein contact mediated mainly by hydrophilic residues. Sequence alignment indicates, among betacoronaviruses, a possible structural conservation for the region homologous to the MERS-CoV RBD core, but a high variation in the external receptor binding motif region for virus-specific pathogenesis such as receptor recognition.
, and are very similar to those caused by SARS-CoV. However, the novel coronavirus diverges from SARS-CoV in genomic sequence, and is much more closely related to the bat-derived HKU4 and HKU5 coronaviruses 7, 8 . Consistent with phylogenetic analysis, MERS-CoV does not use the SARS-CoV receptor, angiotensin converting enzyme 2 (ACE2), as its entry receptor 9 ; rather, a recent study showed that it uses human CD26 for this purpose 4 . CD26 is the third peptidase to be identified as a functional coronavirus receptor, the others being aminopeptidase N (ANPEP, also known as APN and CD13) 10, 11 and ACE2 (ref. 12 ). The recognition of CD26 by MERS-CoV is mediated by virus surface spike (S) protein 4 . As with other coronaviruses, the MERS-CoV S protein would be cleaved in host cells into S1 and S2 subunits (Fig. 1a) . S1 engages the receptor 4 whereas S2, with typical sequence motifs homologous to those identified as the heptad repeats in class I enveloped viruses [13] [14] [15] , should mediate membrane fusion. The exploitation of the virus-receptor interaction and thus of the intervention strategies requires an atomic delineation of the receptor-binding properties of S1. On the basis of previous studies, the receptor attachment sites of coronavirus S1 subunits might locate to either the amino-terminal (such as in murine hepatitis virus 16 ) or the carboxy-terminal (such as in, for example, SARS-CoV 17 and human coronavirus NL63 (ref . 18)) domain. We therefore tested individually the binding of MERS-CoV S1 and its N-and C-terminal-domain proteins to cell-surface-expressed CD26 molecules. The receptor-binding capacity was attributed to the C-terminal amino acids 367-606 of MERS-CoV S1 (Fig. 1b) ), but does not bind to the RBD of SARS-CoV (Fig. 1c) .
We crystallized MERS-CoV RBD and solved its structure at a resolution of 2.5 Å (Supplementary Table 1 ). Two molecules of essentially the same structure are present in the asymmetric unit. Each molecule contains 208 consecutive density-traceable amino acids from V381 to L588. A Dali 19 search within the Protein Data Bank (PDB) revealed clear structural homology between MERS-CoV RBD and SARS-CoV RBD (PDB code, 2DD8; Z score, 15.1). We therefore divided the MERSCoV RBD structure into two subdomains: a core and an external b-sheet, using the structure of SARS-CoV RBD as a reference. The core subdomain reveals a five-stranded antiparallel b-sheet (b1, b3, b4, b5 and b10) in the centre. The connecting helices (four a-helices: a1-4 and two 3 10 -helices: g1 and g2) and two small b-strands (b2 and b11) further decorate the sheet on both sides, together forming a globular fold. Three disulphide bonds, connecting C383 to C407, C425 to C478, and C437 to C585, respectively, stabilize the core-domain structure from the interior. At the solvent-exposed side, the RBD termini are clinched adjacent to each other (Fig. 2a, b) . This subdomain fold is very similar to that of the SARS-CoV RBD core (a root mean squared deviation of 2.79 Å for 76 Ca pairs). Superimposition of the two structures reveals a well-aligned centre sheet and homologous peripheral helices and strands, although several intervening loops are observed to exhibit large conformational variance (Fig. 2c) .
The external subdomain of MERS-CoV RBD is mainly a b-sheet structure with three large (b6, b8 and b9) and one small (b7) strand arranged in an antiparallel manner. It is anchored to the RBD core through the b5/6, b7/8 and b9/10 intervening loops, which touch the core subdomain like a clamp at both the top and bottom positions. Two small 3 10 helices (g3 and g4) and most of the connecting loops in this subdomain locate on the interior side of the sheet, hence exposing a flat exterior sheet-face to the solvent. Residues C503 and C526 form the fourth disulphide bond, linking the g3 helix to strand b6 (Fig. 2a, b) . With no observable structure homology (Fig. 2c) , the external subdomains of MERS-CoV and SARS-CoV RBDs are topological equivalents, both being present as an 'insertion' between the equivalent core-strands (strands b5 and b10 in MERS-CoV, and b6 and b9 in SARS-CoV) ( Supplementary Fig. 1 ).
To elucidate the structural basis of the virus-receptor engagement, we further prepared the RBD-CD26 complex by in vitro mixture of the two proteins and then purification on a gel filtration column. Consistent with the high binding affinity between MERS-CoV RBD and CD26, the complex is easily obtainable and stable ( Supplementary Fig. 2 ). The complex structure was solved at 2.7 Å resolution (Supplementary Table 1 ) with one RBD binding to a single CD26 molecule in the asymmetric unit. The receptor, as shown in previous reports 20, 21 , is composed of an eight-bladed b-propeller domain and an a/b hydrolase domain. MERS-CoV RBD binds to the side-surface of the CD26 bpropeller, recognizing blades IV and V and a small bulged helix in the blade-linker. As for the viral ligand, the entire receptor binding site locates in the external subdomain and to the solvent-exposed sheetface, qualifying the subdomain as the receptor binding motif (RBM) (Fig. 3a) . Overall, engagement of the receptor does not induce obvious conformational changes in RBM, although small structural variance could be observed for the tip-loops. The g2-a4 loop in the RBD core, however, unexpectedly exhibits a large conformational difference between the free and the bounded structures ( Supplementary Fig. 3 ). We believe this is due to a crystal contact present in the free RBD structure, which is interrupted in the complex crystal by the engaging receptor.
CD26 is a type II transmembrane protein. It is present as a homodimer on the cell surface [20] [21] [22] . The dimerization of the peptidase relies on broad intermolecule contacts contributed by the hydrolase domain and the extended strands in blade IV of the b-propeller 20,21 . A lateral binding of MERS-CoV RBD to CD26 would therefore not disrupt CD26 dimerization. Accordingly, a similar U-shaped CD26 dimer could be generated by symmetry operations of the complex structure. The viral ligand locates at the membrane-distal tip of the dimer, corresponding well to a trans interaction between the virus and the receptor (Fig. 3b) . Considering that the RBD N and C termini are on the same side distant from CD26, it is unlikely that the remaining S domains would contact the receptor molecule. The binding mode revealed by the complex structure is also in good accordance with a previous study showing that the virus-receptor interaction is independent of the peptidase activity of CD26 (ref. 4) . The bound RBD is far away from interfering with either the substrate/product accessing tunnels or the catalytic centre 20,21 (Fig. 3b ). Overall, a surface area of 1203.4 and 1113.4 Å 2 in CD26 and MERSCoV RBD, respectively, is buried by complex formation (Fig. 4a) . Scrutinization of the binding interface reveals a group of hydrophilic residues at the site, forming a polar-contact (H-bond and salt-bridge) network. These interactions are predominantly mediated by the residue side chains (including RBD Y499 with CD26 R336, N501 with Q286, K502 with T288, D510 with R317, E513 with Q344, and D539 with K267), although CD26 L294 and RBD D510 are observed to contact RBD R542 and CD26 Y322, respectively, through the mainchain oxygen atom (Fig. 4b) . In addition, the bulged helix in CD26 
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properly positions three hydrophobic residues A291, L294 and I295 into close proximity with the RBD amino acids Y540, W553 and V555, forming a hydrophobic centre at the interface (Fig. 4c) . Further virusreceptor contacts include V341 and I346 of CD26 packing against P515 and the apolar carbon atoms of R511 and E513 in RBD (Fig. 4d) , and a CD26 N229-linked carbohydrate moiety interacting with RBD amino acids W535 and E536 (Fig. 4e) . Overall, the virusreceptor engagement is dominated by the polar contacts mediated by the hydrophilic residues, and mutations of those in RBD (six alanine substitutions and one Y499F mutation of the CD26-interacting amino acids) completely abrogated its interaction with CD26 ( Supplementary  Fig. 4 ). The features of these residue interactions are very similar to those mediating the interaction between adenosine deaminase (ADA) and CD26 (ref. 23). By a pairwise comparison, we unexpectedly found that all those CD26 residues identified in the virus-receptor interface are also involved in ADA binding, indicating a competition between ADA and the virus for CD26 receptor. As the ADA-CD26 interaction is shown to induce co-stimulatory signals in T cells 22 , this may indicate a possible manipulation of the host immune system by MERS-CoV through competition for the ADA-recognition site. It is also noteworthy that those CD26 residues involved in RBD binding are highly conserved between human and bat, with only two variations (I295T and R317Q), explaining the capability of MERS-CoV using bat CD26 for cell entry 4 ( Supplementary Fig. 5 ). Coronaviruses can be categorized into three main genera or groups (group 1 (alpha), group 2 (beta) and group 3 (gamma) coronaviruses) 24 . Both MERS-CoV and SARS-CoV belong to the betacoronavirus genus, but are classified into different lineage subgroups (subgroup 2b for To facilitate comparison, the secondary-structure elements of SARS-CoV RBD (PDB code, 2DD8) are marked with spiral (helices) and arrow (strands) lines below the sequence. The cysteine residues that form disulphide bonds are labelled as in a, and residue N410 with a star. c, A structural alignment between MERS-CoV (magenta for core and cyan for external subdomains) and SARSCoV (green) RBDs.
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SARS-CoV and 2c for MERS-CoV) 8 . We noted that the spike sequences are of low identity among different subgroup members. For example, MERS-CoV and SARS-CoV S proteins show a sequence identity of less than 28%. Nevertheless, RBDs of the two coronaviruses are homologous for the core subdomain. Notably, the three interior disulphide bonds in the core are well-aligned for the steric positions in the two RBD structures and well-conserved in sequence among betacoronaviruses. Conversely, the external RBM region is highly variable in both length and residue composition (Supplementary Fig. 6 ). Consistently, no structural homology in this subdomain is observed between MERSCoV and SARS-CoV. Yet it is this subdomain that engages cellular receptors. We therefore assume that betacoronaviruses probably have a similar core-domain fold in the S protein to present the external amino acids with divergent structures for viral pathogenesis, such as receptor recognition.
Our work presents the fifth structure of virus S protein-receptor complexes in the Coronaviridae family [16] [17] [18] 25 . Taking into account both the RBD structure and the binding mode with receptors, MERS-CoV is related to SARS-CoV 17 (a single insertion functioning as RBM) but differs from porcine respiratory coronavirus 25 and NL63 (ref. 18 ) of alphacoronaviruses (multiple discontinuous RBMs) ( Supplementary  Fig. 7 ). Nevertheless, related structural topologies can still be observed in RBDs of these coronaviruses 26 . We noted that in the RBD-receptor complex structures of both MERS-CoV and porcine respiratory coronavirus the binding interfaces involve a receptor N-glycan. This might represent another cross-genus similarity in the Coronaviridae family, which supports a proposed common evolutionary origin of coronavirus S proteins 26 . It would therefore be interesting to investigate the contribution of the sugar moiety to the virus-receptor interaction for MERS-CoV in the future.
Vaccination remains the most useful measure to combat viral infection and transmission. A large number of antibodies show neutralization activity by targeting the RBD and thereby disrupting the virus-receptor engagement. Therefore, a properly folded RBD could be an ideal immunogen for vaccination, as demonstrated for SARS-CoV
27
. A recent report indeed shows the presence of S-specific neutralizing antibodies in MERS-CoV-infected patients 28 . It may be worth attempting to test the immunization effect of MERS-CoV RBD in the future.
METHODS SUMMARY
Protein expression, purification, crystallization and structure determination. Both His-tagged CD26 and MERS-CoV RBD proteins were expressed in insect High Five cells using the Bac-to-Bac baculovirus expression system (Invitrogen). The recombinant proteins were then purified via nickel-chelated affinity chromatography and gel filtration. Crystals were obtained by initial screening with the commercially available kits followed by optimization. The RBD structure was solved by single-wavelength anomalous diffraction and the complex structure by molecular replacement.
Full Methods and any associated references are available in the online version of the paper. Supplementary Information is available in the online version of the paper.
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